Endoplasmic reticulum stress and organelle crosstalk: Core mechanisms and therapeutic targets in diabetic kidney disease.
文献摘要
Diabetic kidney disease (DKD) remains the leading global cause of end-stage renal disease, with persistent residual renal damage even after standard clinical interventions including SGLT2 inhibitors and GLP-1 receptor agonists. Accumulating preclinical evidence indicates that sustained endoplasmic reticulum (ER) dysfunction may act as an important integrating mechanism contributing to renal cellular injury in DKD, beyond its canonical function in protein folding, although direct clinical evidence in human DKD remains limited. This review examines how interacting diabetic metabolic and inflammatory stressors, including glucotoxicity, lipotoxicity, advanced glycation end products, and chronic inflammation, disrupt ER homeostasis and promote persistent ER stress. Long-term ER perturbation induces a pathogenic shift of the unfolded protein response (UPR) from adaptive homeostasis maintenance toward pro-apoptotic and pro-inflammatory signaling, alongside disordered lipid biosynthesis and Ca 2+ dyshomeostasis. These three core pathological alterations jointly facilitate podocyte and tubular epithelial cell apoptosis, sterile renal inflammation and progressive interstitial fibrosis, while altered mitochondria-associated ER membrane (MAM) dynamics may amplify organelle injury and exacerbate disease progression. We further discuss multiple therapeutic strategies targeting ER homeostasis restoration, such as chemical molecular chaperones, selective UPR pathway modulators, SREBP lipogenic inhibitors, SERCA calcium pump activators and MAM stabilizers. We also discuss the potential contribution of ER homeostasis to the renoprotective effects of SGLT2 inhibitors and GLP-1RAs. Overall, ER dysfunction may contribute to DKD pathogenesis and represents a potential therapeutic target, although its mechanistic significance in human DKD requires further investigation.